|
|
|
 22/01/2010
[Industry news]
China-Biotics, Inc. Appoints New Chief Financial Officer
China-Biotics, Inc. a leading Chinese firm specialising in the manufacture, research, development, marketing and distribution of probiotics products, today announced the appointment of Mr. Travis Cai as Chief Financial Officer, effective January 22, 2010.
|
| |
|
China-Biotics, Inc. a leading Chinese firm specialising in the manufacture, research, development, marketing and distribution of probiotics products, today announced the appointment of Mr. Travis Cai as Chief Financial Officer, effective January 22, 2010. Mr. Cai replaces Ms. Eva Yan, who has served as Interim Chief Financial Officer of China-Biotics since Mr. Lewis Fan resigned as Chief Financial Officer on October 21, 2009. Mr. Cai brings more than 10 years of professional and corporate finance experience with public companies and investment institutions. His areas of expertise include financial management, mergers and acquisitions, investor relations, risk controls, SOX 404 compliance, and SEC reporting. Prior to joining China-Biotics, Mr. Cai was Vice President of Finance at A-Power Energy Generation Systems Ltd. from 2009 to January 2010. He previously served as Director of Finance and Assistant to President at Vimicro International Corp. from 2007 to 2009. Both companies are operating in China and listed on NASDAQ. Mr. Cai holds a Master of Science degree in Information Systems from the Stern School of Business, New York University, and a Bachelor of Science degree in Materials Science & Engineering from Tsinghua University. He is certified as a Financial Risk Manager by the Global Association of Risk Professionals (GARP).
\"We are delighted to enhance our financial management team with the appointment of Mr. Travis Cai as our new Chief Financial Officer,\" said Mr. Jinan Song, Chairman and Chief Executive Officer of China-Biotics. \"We believe his wide range of corporate accounting and finance experience will make a significant contribution to our senior executive team as China-Biotics continues to execute on its growth strategies in the coming years.\" |
|
|
|
|
